Skip to main content

Table 5 Clinical outcomes of patients infected with resistance to both BDQ and LZD

From: Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition

Patient ID

Patient category

Drug susceptibility

Mutation conferring BDQ resistance

Mutation conferring LZD resistance

Treatment regimen

Sputum culture conversion

Clinical outcome

040,012

Previously treated

MDR

WT

Cys154Arg (rplC)

Bdq/Lzd/Mfx/Cs/Am/Pto

8 weeks

Cured

010,121

Previously treated

XDR

Ile108Thr (Rv0678)

WT

Bdq/Lzd/Mfx/Cs/Cfz/Am

NA

Treatment failure

  1. MDR, multidrug-resistance; XDR, extensive drug-resistance; BDQ, bedaquiline; LZD, linezolid; Mfx, moxifloxacin; Cs, cycloserine; Am, amikacin; Pto, protionamide; Cfz, clofazimine; NA, not available; WT, wild-type